Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs
- PMID: 2890117
- DOI: 10.1016/0028-3908(87)90094-3
Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs
Abstract
The intravenous injection of cisplatin in the ferret caused a consistent emetic (vomiting/retching) response. Emesis induced by cisplatin was abolished by the 5-hydroxytryptamine (5-HT) M-receptor antagonists ICS205-930, zacopride, dazopride and metoclopramide. The neuroleptic agents haloperidol, fluphenazine, domperidone, sulpiride and tiapride also antagonized emesis induced by cisplatin but only a proportion of the animals were completely protected and diazepam and prednisolone only reduced the intensity of the response. It is concluded that compounds used in the clinic to antagonise emesis induced by chemotherapy are effective in the ferret model. Antagonism of emesis induced by cisplatin in the ferret was most potently achieved by the use of the 5-HT M-receptor antagonists ICS205-930 and zacopride. However, an antagonism of dopamine receptors would appear relevant to the anti-emetic effects of the neuroleptic agents and may contribute to the anti-emetic effects of metoclopramide. Diazepam and prednisolone exert their modest antagonism by unknown mechanisms. The use of the 5-HT M-receptor antagonists is revealed as a novel approach to the treatment of emesis induced by cisplatin.
Similar articles
-
5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis.Neuropharmacology. 1986 Aug;25(8):959-61. doi: 10.1016/0028-3908(86)90030-4. Neuropharmacology. 1986. PMID: 3774121
-
The actions of fenfluramine and interaction with 5-HT3 receptor-antagonists to inhibit emesis in the ferret.J Pharm Pharmacol. 1990 Feb;42(2):94-101. doi: 10.1111/j.2042-7158.1990.tb05361.x. J Pharm Pharmacol. 1990. PMID: 1972409
-
An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.Br J Pharmacol. 1996 May;118(2):209-14. doi: 10.1111/j.1476-5381.1996.tb15388.x. Br J Pharmacol. 1996. PMID: 8735616 Free PMC article.
-
Neuropharmacology of emesis in relation to clinical response.Br J Cancer Suppl. 1992 Dec;19:S2-7; discussion S7-8. Br J Cancer Suppl. 1992. PMID: 1467196 Free PMC article. Review.
-
5HT3-antagonist receptors: their role in drug-induced emesis.Nouv Rev Fr Hematol (1978). 1990;32(6):449-52. Nouv Rev Fr Hematol (1978). 1990. PMID: 1983228 Review.
Cited by
-
Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.Drugs. 1997 Feb;53(2):206-34. doi: 10.2165/00003495-199753020-00003. Drugs. 1997. PMID: 9028742 Review.
-
A serotonergic mechanism for the metoclopramide-induced increase in aldosterone level?Eur J Clin Pharmacol. 1994;47(4):377-8. doi: 10.1007/BF00191172. Eur J Clin Pharmacol. 1994. PMID: 7875192 No abstract available.
-
5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.Br J Pharmacol. 1995 Jan;114(2):269-74. doi: 10.1111/j.1476-5381.1995.tb13222.x. Br J Pharmacol. 1995. PMID: 7881726 Free PMC article.
-
Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience.Support Care Cancer. 1994 Nov;2(6):393-9. doi: 10.1007/BF00344055. Support Care Cancer. 1994. PMID: 7858934 Clinical Trial.
-
Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.Drugs. 1993 Nov;46(5):925-43. doi: 10.2165/00003495-199346050-00009. Drugs. 1993. PMID: 7507039 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical